Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 1 1

Status

Completed 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Breast 2

Conditions

Motor Activity 9Breast Neoplasms 6Neoplasms 4Colorectal Neoplasms 3Multiple Myeloma 2Insulin Resistance 2Cardiotoxicity 2Weight Loss 1Warts 1Skin Neoplasms 1Prostatic Neoplasms 1Polycystic Ovary Syndrome 1Peripheral Nervous System Diseases 1Ovarian Neoplasms 1Multiple Endocrine Neoplasia Type 1 1Melanoma 1Lymphoma 1Limb-girdle muscular dystrophy, type 2C 1Leukemia, Myeloid, Acute 1Hematologic Neoplasms 1Fatigue 1Diabetes Mellitus, Type 2 1Diabetes Mellitus 1Cognitive Dysfunction 1Carcinoma, Hepatocellular 1Cachexia 1Brenner Tumor 1Bone Metastases 1Body Weight 1

Interventions

Exercise 2Doxorubicin 2Carvedilol 2Trastuzumab 1Reverse Transcriptase Polymerase Chain Reaction 1Paclitaxel 1Metformin 1Mass Spectrometry 1Magnetic Resonance Spectroscopy 1Lisinopril 1Lapatinib 1Gene Expression Profiling 1Fluorophotometry 1Exercise Test 1Cyclophosphamide 1Chemotherapy, Adjuvant 1Atorvastatin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Has results × Cardiotoxicity × Exercise × Clear all
NCT01719562 2023-05-19

MRI in Detecting Heart Damage in Patients With Cancer Receiving Chemotherapy With Exercise Capacity Addendum

Wake Forest University Health Sciences

Phase NA Completed
28 enrolled 17 charts
Breast

Breast Neoplasms, Neoplasms, Cardiotoxicity

NCT02006979 2019-10-25

Acute Exercise Cardioprotection From Doxorubicin

University of British Columbia

Phase 1 Completed
27 enrolled 18 charts
Breast

Breast Neoplasms, Motor Activity, Cardiotoxicity

Data powered by HemOnc (CC BY 4.0) Colophon âš¡